When to Stop IVF: How Doctors Have the Conversation

If you are reading this, you are sitting with one of the heaviest conversations in fertility medicine, and I want you to know before any data appears below that this is not a "give up" post and it is not a "you should stop" post. You have done two, three, four cycles. Your RE has either named this conversation plainly or has been circling it, and you are here because you want the honest math and you want permission: to keep going, or to stop.

When to stop IVF is not a medical failure question. It is a decision made when the data has shifted. I have walked patients to this decision and I have walked patients past it. Both are right answers for the right people. The data does not make the choice for you. It frames what choosing actually means.

What this post is: and what it is not

This post exists because too many couples reach this point without the numbers and without a vocabulary for the conversation. Their RE says something careful, they go home and panic, they come back two weeks later not knowing what to ask.

It is not advice that you should stop. It is not advice that you should continue. It is the data your doctor is reading, the alternative paths that are not actually "stopping" at all, and the shape a good version of this conversation has. The decision is yours and your partner's, if you have one.

The data that drives the conversation

There are four findings that move REs toward naming this conversation. Most patients reach the conversation through a combination of two or three of them.

Cumulative live birth plateaus: The Smith et al. JAMA 2015 dataset of 156,000 women showed that cumulative live birth per egg retrieval rises across cycles one through three and then begins to plateau around cycles four through six, depending on age.¹ The Malizia et al. NEJM 2009 dataset showed similar curves with regional differences.² What this means in practice: cycle five is rarely much more productive than cycle four was, and the cost-per-additional-success rises steeply.

Age and own-egg ploidy: Past 42-43 with own eggs, per-cycle live birth rates fall under five percent in most clinic data, and even cumulative rates across several cycles stay under 15-20 percent. Aneuploidy is the main driver. It is the reason most clinics, after a certain point, will name the donor-egg option as a higher-probability path.

Repeated cycle failure with completed workup: The 2023 ESHRE good practice on recurrent implantation failure defines RIF as failure after three high-quality or equivalent euploid embryo transfers in someone under 40.³ Three euploid transfers without a live birth and with a negative RIF workup is a finding that shifts the per-transfer probability downward, not to zero, but meaningfully.

Cohort-level issues that recur: Persistent cancellations for under-response despite protocol changes. Cycle after cycle with no blastocysts despite reasonable retrieval numbers. Consistently aneuploid cohorts across multiple PGT-A cycles in advanced maternal age. These are findings about the cohort, not about a single cycle.

When two or three of these are present, a good RE will name the conversation. Not as a verdict, but as information.

When to stop IVF: five scenarios REs typically raise

In practice, these are the five patterns I see most often.

• Repeated cycle cancellation with no protocol that has produced a complete cycle, especially in low-AMH or POSEIDON group 3-4 profiles.
• Persistent inability to produce blastocysts across multiple stim cycles despite fertilization.
• All embryos aneuploid across multiple PGT-A cycles in advanced maternal age, where the cohort-level picture is the constraint.
• Three or more failed euploid transfers with a completed RIF workup that is negative.
• A severe medical complication (hospitalization for OHSS, complication during retrieval, anesthesia event) that creates a real safety concern for further treatment.

These are not absolute thresholds. They are patterns that justify having the conversation. None of them, by themselves, mean you must stop.

The alternative paths that are not "stopping"

The framing of "continue versus stop" is incomplete because it leaves out the paths that are not own-egg IVF. Some of these become the right answer at exactly the point where own-egg IVF probability has fallen below what is reasonable.

Donor egg IVF: Live birth rates run approximately 50-55 percent per fresh transfer regardless of recipient age, because the egg is from a younger donor. This is the biggest single change in probability available in fertility medicine. It is also an enormous emotional shift (genetic, identity, family, disclosure decisions) and not a small one. Many people need months to consider it; some never feel right about it; some find it the most freeing decision they made. None of those reactions are wrong.

Donor sperm: Relevant in severe male factor where surgical sperm extraction and ICSI are not options or have not worked. Same emotional terrain as donor egg, with different specifics.

Donor embryo: Increasingly available, significantly lower cost than donor egg, often through clinic-based programs or independent matching. The legal and disclosure decisions overlap with adoption in some ways.

Gestational carrier: For uterine factor or medical conditions that make pregnancy unsafe. Legal and financial complexity, particularly in the US, with state-by-state variation.

Adoption: A separate timeline and process, not "next IVF." A real family-building path with its own grief, its own joy, and its own learning curve.

Childfree life: Also a path. Also a real choice. Also a legitimate response to the data. Couples who choose this and then build a life around it report, in long-term follow-up, comparable life satisfaction to couples who pursued and achieved pregnancy.⁴ This is not a consolation prize. It is a real choice some people make and continue to choose for the rest of their lives.

The financial and emotional math

Money matters here and we are not going to pretend it does not. A fifth IVF cycle at age 43 with own eggs has a low expected return per dollar. The same dollars allocated to a donor egg cycle have a 2-3x higher expected probability of live birth. If finances are constrained, which they are for almost everyone, the allocation question is real.

Treatment fatigue is also measurable. The Domar et al. 2010 dropout study found that the most common reason insured US patients discontinued IVF was psychological burden, not financial constraint or medical advice.⁶ Most couples who stop, stop because they are tired in a way that the next cycle cannot fix.

Depression and anxiety rise sharply across cycles, particularly past cycle three. Partner relationships strain in predictable ways. If you have not seen a fertility-trained therapist, this is the point in the journey where one is most useful. Boivin and Gameiro's 2015 review summarizes the evidence for psychological care during treatment cessation.⁴

How a good RE has this conversation

There is a version of this conversation that respects you and a version that does not. The version that respects you names the data, not a verdict. It offers options (continue with own eggs, switch to donor, pause, stop, donor embryo, adoption) without ranking them morally. It refers to mental health and fertility counseling, not as an aside but as part of the care plan. It does not pressure either direction. It allows time. It revisits, because this is rarely a one-meeting decision.

The version that does not respect you pushes one direction, usually with financial implications attached. If continuation is being pushed without data presentation, or if stopping is being pushed without exploring donor or alternative paths, that is your signal to seek a second opinion. The ASRM Ethics Committee has written on the equity and access issues that shape these conversations and is worth reading.⁵

Red flags in the "stopping" conversation

These are the patterns I would push back on as a second-opinion physician.

• An RE pushing one direction without showing you the data.
• No discussion of cumulative live birth math by age band.
• No referral to mental health support or fertility counseling.
• Pressure to continue with very low-probability cycles when clinic financial incentives are visible.
• Pressure to stop without any exploration of donor egg, donor embryo, or gestational carrier paths.
• Refusal to put projections in writing or to break out numbers by age.

A second opinion at this stage is reasonable and common. Most REs expect it.

Stopping with eggs or embryos still in the freezer

A particularly hard variant. If you have frozen embryos and you have decided to stop active treatment, those embryos do not go away. They sit in storage, and storage fees continue, and at some point decisions about disposition are required.

The options are well-defined and all legitimate:

• Continued storage, indefinitely, while you decide.
• Donation to another couple, sometimes called embryo adoption.
• Donation to research, where regulations allow.
• Discard, in accordance with clinic and state protocols.

Many people pause for months or years before deciding, and the pause is itself a valid choice. The embryos are also a real grief, even before any decision is made. This is one of the situations where a fertility-trained therapist is most useful, because the decision touches on identity, religion, family, and loss in layered ways.

Stopping after never reaching transfer

The other hard variant. If your cycles ended in cancellations, failed fertilization, or no blastocysts, you have a different grief than someone whose cycles ended in failed transfers. There was never an embryo. There was never a positive test. Many readers in this position describe feeling that they "did not even get a chance," and the grief is real and complete. The medicine that did not happen is still a loss.

What to ask your RE if this conversation is on the horizon

Bring these to the consult on paper.

1. What is my cumulative live birth probability if we continue with own eggs for two or three more cycles?
2. What would that number be with donor eggs?
3. What is your honest read on whether continued cycles with own eggs are reasonable?
4. Are there any workup items we have not yet done?
5. Can you refer me to a fertility-trained therapist?
6. If we wanted to pause for three to six months, would that compromise anything medically?

What you can do tonight

Almost nothing, and that is on purpose.

Read this. Then close the tab. Do not make the decision tonight. The cumulative live birth math does not change in two weeks; your nervous system might. Sit with what you read for at least one menstrual cycle before any meeting where a decision is made.

Talk to your partner if you have one. Not in the kitchen, and not right after a clinic visit. Somewhere quieter. Each of you may be in a different place about this, and that is common and is not a relationship problem to solve in one conversation.

If you do not already have a fertility-trained therapist, this is the moment to find one. RESOLVE maintains a US directory; many clinics have referrals. The when to stop IVF decision is hard enough without doing it alone.

If you need the grief library, our setback content lives at when-things-dont-go-to-plan/grieving-a-failed-transfer and when-things-dont-go-to-plan/childfree-after-infertility. Both were written for exactly this place.

What's next

• If you are continuing with own eggs and need cycle-two planning: /ivf/second-ivf-cycle-changes
• If you are at the RIF threshold: /ivf/recurrent-implantation-failure
• If you are exploring donor egg: /when-things-dont-go-to-plan/donor-egg-decision
• If childfree is the path you are considering: /when-things-dont-go-to-plan/childfree-after-infertility
• If you are seeking a second opinion: /getting-diagnosed/picking-an-re

Related in this cluster

• Failed IVF Transfer: What Doctors Look For Before the Next One

Sources

1. Smith ADAC, Tilling K, Nelson SM, Lawlor DA. Live-birth rate associated with repeat in vitro fertilization treatment cycles. JAMA 2015;314(24):2654-2662. https://doi.org/10.1001/jama.2015.17296
2. Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. New England Journal of Medicine 2009;360(3):236-243. https://doi.org/10.1056/NEJMoa0803072
3. Cimadomo D, de Los Santos MJ, Griesinger G, et al. ESHRE good practice recommendations on recurrent implantation failure. Human Reproduction Open 2023;2023(3):hoad023. https://doi.org/10.1093/hropen/hoad023
4. Boivin J, Gameiro S. Evolution of psychology and counseling in infertility. Fertility and Sterility 2015;104(2):251-259. https://doi.org/10.1016/j.fertnstert.2015.05.035
5. Ethics Committee of the American Society for Reproductive Medicine. Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion. Fertility and Sterility 2021;116(1):54-63. https://doi.org/10.1016/j.fertnstert.2021.02.019
6. Domar AD, Smith K, Conboy L, Iannone M, Alper M. A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment. Fertility and Sterility 2010;94(4):1457-1459. https://doi.org/10.1016/j.fertnstert.2009.06.020